Top investors: 5 later-stage raise strategies for 2025
Learn insider strategies for your later-stage raise. Discover what top investors at TechCrunch Disrupt 2025 are looking for and how to prepare your company for success.
Read More
cw profile grows with top 25 college football matchup
The unexpected broadcast of a Top 25 college football game is giving the cw profile a major boost, expanding its audience and brand beyond its typical programming.
MLB Insiders: 2 Huge Contract Predictions This Winter
How much will Kyle Tucker and Kyle Schwarber get? Top MLB insiders predict the details of their massive free agency contracts ahead of the upcoming MLB winter meetings.
Fiercest Women in Life Sciences: Nominate for 2025
Nominations are now open for the Fiercest Women in Life Sciences 2025 awards. Help us recognize the most innovative and inspiring leaders in biopharma and medtech.
Kyle Tucker Contract: 9 MLB Insiders Predict His Payday
How much will Kyle Tucker get paid in free agency? MLB insiders predict the future contract for the Astros star, plus a look at Kyle Schwarber’s potential deal.
expected trends: 5 styles for ariana grande’s tour
What are the expected trends for Ariana Grande’s Eternal Sunshine tour? We predict the top fashion styles, from Y2K throwbacks to ethereal, dreamy gowns.
Court orders ‘tribe’ of 30 to leave Scottish woodland
A Scottish court orders ‘tribe’ known as the Dùn an Rìgh to be evicted from their woodland home. The long-standing legal battle concludes with this final ruling.
Eli Lilly: 1 Big Reason for UK Gateway Lab Reconsideration
Reports suggest pharmaceutical giant Eli Lilly is reconsidering its major UK Gateway Lab investment. Learn why the company’s future plans in Britain are now uncertain.
Novo Nordisk: Employees Must Return to Office Jan. 1
Novo Nordisk has announced a mandatory return-to-office policy for all employees, effective January 1. Learn more about the new workplace rules for the pharma giant.
New Drugs: 1 Major FDA Change Under Trump to Watch
Under Trump, the FDA seeks to abandon expert reviews of new drugs. Learn how this major policy shift could affect the safety and approval process for all new drugs.